A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make ...

So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...